NIMODIPINE

作品数:75被引量:210H指数:8
导出分析报告
相关领域:医药卫生更多>>
相关作者:曹美鸿陈立华袁贤瑞王磊蔡景霞更多>>
相关机构:中国科学院中国药科大学第三军医大学中国医学科学院北京协和医学院更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划国家高技术研究发展计划天津市自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 基金=国家重点基础研究发展计划x
条 记 录,以下是1-2
视图:
排序:
The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized,placebo-controlled trial被引量:8
《Science Bulletin》2019年第2期101-107,共7页Huaguang Zheng Yilong Wang Anxin Wang Hao Li David Wang Xingquan Zhao Penglian Wang Haipeng Shen Lijun Zuo Yuesong Pan Zixiao Li Xia Meng Xianwei Wang Weixiong Shi Yi Ju Liping Liu Kehui Dong Chunxue Wang Rubo Sui Rong Xue Xiaoping Pan Xiaoyua Niu Benyan Luo Yi Sui Huali Wang Tao Feng Yongjun Wang 
supported by the National 11th&12th Five Year S&T Major Projects(2011BAI08B01,2011BAI08B02);the National Key Technology Research and Development Program of the Ministry of Science and Technology of China(2013BAI09B03);the Ministry of Science and Technology of China(2012ZX09303-005-001);Beijing Biobank of Cerebral Vascular Disease(D131100005313003)
Nimodipine might be effective in subcortical vascular dementia(VaD). Its benefit in preventing further cognitive decline in patients with acute ischemic stroke(AIS) and vascular mild cognitive impairment(VaMCI) remain...
关键词:NIMODIPINE Acute ISCHEMIC stroke Mild COGNITIVE IMPAIRMENT COGNITIVE DECLINE Prevention 
Hot spots and future directions of research on the neuroprotective effects of nimodipine被引量:7
《Neural Regeneration Research》2014年第21期1933-1938,共6页Runhui Li 
The National Natural Science Foundation of China;the National Key Basic Research and Development Program(973 Program)of China sponsored 18 of the articles retrieved in our search;The National Commission on Science and Technology Development in Brazil sponsored 6 publications;The Coordenao de Aperfeioamento de Pessoal de Nível Superior(the Brazilian Federal Agency for the Support and Evaluation of Graduate Education)sponsored four publications;the Oak Ridge Institute for Science and Education;NIH Project;Kyung Hee University;German Federal Ministry of Education and Research;Bayer Vital Gmb H Leverkusen each provided funding for two studies(Figure 5)
Calcium antagonists are widely used in the clinical treatment of ischemic cerebrovascular disease because of their vascular and neuroprotective effects. Nimodipine, a typical calcium antagonist, can cross the blood-br...
关键词:NEUROPROTECTION nerve regeneration NIMODIPINE ischemic cerebrovascular disease Web of Science CiteSpace research fronts development trends scientific mapping VISUALIZATION 
检索报告 对象比较 聚类工具 使用帮助 返回顶部